Erste Group Downgrades Regeneron Pharma (REGN) to Hold, 'sales growth will be impaired'
Tweet Send to a Friend
(Updated - September 30, 2024 7:18 AM EDT)
Erste Group analyst Hans Engel downgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Erste Group analyst Hans Engel downgraded Regeneron Pharma (NASDAQ: REGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
